Stock Comments / EPS Changes
CEVA (CEVA) 12-month price target was lowered at Barclays. Still in transition in the near term with lower price product mix, Barclays said. $20 price target and overweight rating.
Charles River Laboratories (CRL) 12-month price target was lowered at Jefferies. Preclinical activity still favoring headwinds, Jefferies said. Twelve-month price target is $66. Buy rating.
Express Scripts (ESRX) 12-month price target was cut at Barclays. Driven by lingering winter weather effects and contract implementation delays, Barclays said. Twelve-month price target is $83. Overweight rating.
Must Read: Analysts' Actions: ADSK AGN BBRY DECK DWA
Facebook (FB) was added to the US Focus List at Credit Suisse. Twelve-month price target is $90.
Flextronics International (FLEX) 12-month price target was increased at UBS. Driven by consistent execution with operating-expense control and consistency in share repurchase, UBS said. Twelve-month price target is $9.50. Neutral rating.
International Paper (IP) 12-month price target was increased at Jefferies. Valuation call with strengthening fundamentals, Jefferies said. Twelve-month price target is $56. Buy rating.
Level 3 Communications (LVLT) 12-month price target was raised at UBS. Top-line returns to growth with EMEA revenue growth to accelerate in the second half. $43 price target and neutral rating.
Wellpoint (WLP) estimates, 12-month price target were boosted at Credit Suisse. Price target is now $109. Estimates were also increased, given the company's new guidance, Credit Suisse said. Neutral rating.